STOCKWATCH: In biotech poker pairs can beat a full house
This article was originally published in Scrip
Executive Summary
Amid ‘lackluster’ quarterly results, there has been a lot of talk about rotation, which is investor slang for cashing out and looking for the next big opportunity. When the biotech sector (scripintelligence.com, 8 October 2013) and, more recently to a lesser extent, the pharmaceutical sector, perform well against the general market, there is always the worry that investors will take profits and move on. This has become much more acute in the past few weeks.